Abstract: A peristaltic pump tube holder has a body having first and second pump tube connectors extending outside of it. The pump tube connectors extend at an acute angle relative to a surface of the body to receive a flexible tubing loop and orient the tubing loop for engagement with an external peristaltic pump rotor.
Type:
Grant
Filed:
December 22, 1993
Date of Patent:
June 27, 1995
Assignee:
Baxter International Inc.
Inventors:
Arthur S. Chapman, T. Michael Dennehey, Richard I. Brown, Warren P. Williamson
Abstract: Systems and methods resuspend cellular-rich concentrates of blood by rocking the separation chamber to create variable agitation forces within the separation chamber. The systems and methods also add resuspension fluids to aid the resuspension.
Abstract: Peritoneal dialysis systems and methods apply fluid pressure to move liquid. The systems and methods can emulate either a fixed head height condition or different head height conditions, independent of the actual head height differential between the patient's peritoneal cavity and the external liquid source or destination. The systems and methods can also switch between low-relative pressure flow mode when considerations of patient comfort and safety predominate and a high-relative pressure flow mode when considerations of processing speed predominate.
Abstract: A blood bag comprises a plastic polyvinyl chloride formulation in which the polyvinyl chloride formulation contains from 5 to 30 percent by weight of a first plasticizer material which is essentially nonextractable by blood plasma stored in the bag up to 35 days at about 4.degree. C.; and from 10 to 25 percent by weight of a second plasticizer which is significantly extracted by blood plasma stored in the bag up to 35 days at about 4.degree. C.
Type:
Grant
Filed:
March 17, 1989
Date of Patent:
January 17, 1995
Assignee:
Baxter International Inc.
Inventors:
Henry M. Gajewski, Barry H. Vernick, Paul E. Measells, Jan W. Garber
Abstract: Systems and methods for separating a suspension of plasma and platelets from whole blood rotate a chamber about an axis to create within the chamber a low-G zone radially close to the axis and a high-G zone spaced radially further from the axis than the low-G zone. The systems and methods introduce whole blood into an inlet region of the chamber to initiate separation of red blood cells toward the high-G zone of the inlet region. This creates a strong flow of plasma that moves radially toward the low-G zone of the inlet region and elutes platelets into suspension with it. The systems and methods direct the radial flow of plasma and eluted platelets within the inlet region to a port in the inlet region for transport out of the chamber. The systems and methods also drag the interface into this radial plasma flow, eluting even the largest of platelets into suspension for collection.
Abstract: A drawer-mounted centrifuge provides easy access for loading and unloading disposable processing elements. The centrifuge also includes an umbilicus holder that moves between an operating position and an out-of-the-way position as the drawer opens and closes.
Abstract: A centrifuge provides simplify access to the processing chamber. In one arrangement, the processing chamber separates into a bowl and spool element to receive a disposable processing bag. In another arrangement, the processing chamber pivots between an operating position and an access position to provide improved access. The centrifuge also employs readily accessible holders for releasably retaining tubing that, in use, conveys fluid to and from the chamber. Though greatly accessible, the centrifuge operates without the need of complicated rotating seals and expensive disposable components.
Type:
Grant
Filed:
November 2, 1993
Date of Patent:
November 1, 1994
Assignee:
Baxter International Inc.
Inventors:
Warren P. Williamson, IV, Richard I. Brown
Abstract: Peritoneal dialysis systems apply fluid pressure to move liquid. The systems can emulate either a fixed head height condition or different head height conditions, independent of the actual head height differential between the patient's peritoneal cavity and the external liquid source or destination. The systems can also switch between low-relative pressure flow mode when considerations of patient comfort and safety predominate and a high-relative pressure flow mode when considerations of processing speed predominate.
Type:
Grant
Filed:
March 3, 1993
Date of Patent:
September 27, 1994
Assignee:
Deka Products Limited Partnership
Inventors:
Dean Kamen, Geoffrey P. Spencer, Douglas E. Vincent
Abstract: Improved Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish an improved chamber for holding the implanted cells. The chambers include first and second wall elements and an intermediate sealing element. The first and second wall elements overlie an open area in the sealing member to form a chamber for holding cells for implantation. A sealed region is created between the wall elements and the sealing element body to close the chamber. In one arrangement, the sealed region is created by means of a sonic weld made while the implanted cells are present in the chamber. In another arrangement, the sealed region is created by means of applying an external force to compress the peripheral edges of the wall elements and the sealing element together while the implanted cells are present in the chamber.
Type:
Grant
Filed:
April 1, 1992
Date of Patent:
September 6, 1994
Assignee:
Baxter International Inc.
Inventors:
Robert A Clarke, Robin G. Pauley, Ronald S. Hill, James H. Brauker, Shmuel Sternberg, Daniel R. Boggs
Abstract: Systems for performing peritoneal dialysis allow the user to chose from an array of peritoneal dialysis modalities and adjust one or more individual therapy parameters within a selected modality. Still, the systems assure that the selected modality and therapy parameters satisfy preselected composite therapy criteria.
Type:
Grant
Filed:
March 3, 1993
Date of Patent:
June 28, 1994
Assignee:
Baxter International Inc.
Inventors:
Lisa Colleran, Rie Inoue, Mark Senninger
Abstract: A system for monitoring the interface region between cellular constituents and plasma in a blood separation chamber employs a sensor mechanism for emitting upon the interface region energy that is absorbed by the cellular constituents. The sensor mechanism also detects the intensity of the energy that is not absorbed by the interface region to generate an unabsorbed intensity output signal. The system moves the interface region relative to the sensor mechanism during a prescribed time period. A first circuit measures variations in the unabsorbed intensity output signal over the prescribed time period and generates a time based output. A second circuit can derive the physical size of the interface region based upon the time based output.
Abstract: Systems transmit a control signal between a rotating element and a stationary element of a blood separation centrifuge. The systems employ a sensor mechanism carried by one of the rotating and stationary elements. The sensor mechanism senses an operating condition that is subject to change. The sensor mechanism generates a first output signal that varies according to changes in the sensed operating condition. A first data transfer component on the one element that carries the sensor mechanism emits energy to the other element without mechanical contact with the other element. The first data transfer mechanism modulates the emitted energy according to variations occurring in the intensity of the first output signal. A second data transfer component on the other element receives the modulated energy emitted by the first data transfer component.
Abstract: Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish a boundary between the host and the implanted cells. The boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells during the critical ischemic period and afterward. The boundary allows the fabrication and clinical use of implant assemblies and methodologies that can carry enough cells to be of therapeutic value to the host, yet occupy a relatively small, compact area within the host.
Type:
Grant
Filed:
April 1, 1992
Date of Patent:
May 24, 1994
Assignee:
Baxter International Inc.
Inventors:
James H. Brauker, Ronald S. Hill, Laura A. Martinson, Daniel R. Boggs, Robert C. Johnson
Abstract: A system and method for treating a fluid carrying a biological contaminant to which a photoactive material has been bound include a treatment device that defines a flow passage with a gap. The system and method operate to establish a flow of fluid from the inlet end of the gap to the outlet end of the gap. The system and method expose the fluid, as it transits the gap, to a source of radiation that activates the photoactive material bound to the contaminant. The system and method also mix the fluid as it flows within the gap.
Type:
Grant
Filed:
December 17, 1992
Date of Patent:
April 5, 1994
Assignee:
Baxter International Inc.
Inventors:
Daniel F. Bischof, Ludwig Wolf, Jr., John T. Foley, William R. Bratten
Abstract: Systems for treating a fluid carrying a contaminant to which a photoactive material has been bound include a treatment device that defines a relatively narrow, arcuately shaped flow path. These systems envelop the path with a radiation chamber that directs radiation from one or more sources into the fluid.
Type:
Grant
Filed:
December 17, 1992
Date of Patent:
March 1, 1994
Assignee:
Baxter International Inc.
Inventors:
Ludwig Wolf, Jr., John T. Foley, William R. Bratten
Abstract: Systems and methods of collecting blood cells use a first container connected to at least three transfer containers. A filtration system is provided with one transfer container, which ultimately serves as the storage container for red blood cells free of white blood cells. The two other transfer containers are connected to each other, one of which is empty and one of which contains and additive solution for storage of red blood cells. The empty transfer container is used for storage of platelet concentrate, while the container that originally contained the additive solution is ultimately used to store the platelet-poor plasma component. A portion of the additive solution may be separately passed through the filtration system after filtration of the red cells to flush additional red blood cells from the filtration device.
Abstract: A processing system separates a cellular rich suspension into a cellular first constituent and cellular-free second constituent. The system includes a separation zone that receives the cellular rich suspension and discharges the first and second constituents. The system coordinates the flow of cellular rich suspension into the separation zone with the flow of the cellular-free second constituent from the separation zone to get a desired nominal separation efficiency. The system also recirculates the cellular first constituent back into the zone. By continuously recirculating the cellular first constituent back into the separation zone, the system is can get and maintain a desired volume of the first constituent, despite the volume of cellular rich suspension that is processed.
Abstract: Methods and systems for collection of blood components, such as plasma, from donors are provided. One method includes the steps of collecting a unit of whole blood from a donor; forcing the collected blood unit through a plasma separator; accumulating the plasma in a container; and returning concentrated cells to the donor. One system includes a disposable blood collection set and a reusable fixture into which the collection set can be mounted. The fixture is operated by a self-contained energy source, requiring no exterior electrical connection or other external source of energy.
Type:
Grant
Filed:
March 21, 1990
Date of Patent:
August 3, 1993
Assignee:
Baxter International Inc.
Inventors:
Michael J. Lysaght, Daniel R. Boggs, Philip L. Ritger, Robert R. Stromberg, Leonard I. Friedman
Abstract: Blood separation is accomplished by alternately extracting blood from and reinfusing blood into a donor by way of a single needle while simultaneously and continuously separating the extracted blood into constituents. A harness set applicable to a hemapheresis instrument includes a dual-compartment reservoir. A first compartment stores blood during extraction for supply to the separator during reinfusion. The second compartment stores packed cells during collection for return to the donor during reinfusion. The collection and reinfusion cycles are alternated rapidly to preclude clotting in the un-anticoagulated portion of the harness tubing between the venepuncture needle and the Y-connection with the anticoagulant line.